The use for nearly two decades of sperm from a single donor carrying a genetic mutation associated with an extreme risk of cancer has highlighted serious ethical and regulatory gaps in assisted reproduction.

The case, which affects around 200 children born in several European countries, calls into question the adequacy of genetic testing, donor anonymity, and the lack of international limits on the use of gametes. This opens a serious debate about healthcare responsibility, children’s right to know their biological origins, and the consequences of turning the transmission of life into a business.

The TP53 gene, known as the “tumor suppressor gene,” is fundamental to the mechanisms in the human body that prevent or slow the growth of cells that could become tumors. The protein encoded by this gene regulates cell division, repairs damaged DNA, and initiates the normal process of cell death (apoptosis) in cells that cannot be repaired.

If this gene has a mutation, the tumor protein 53 (TP53) that it encodes will not perform its preventive function, exposing the affected person to a significant increase in the risk of developing tumors or cancer.

This mutation can be acquired or inherited and is known as Li-Fraumeni syndrome. It carries a risk of up to 90% developing cancer, especially during childhood, as well as breast cancer later in life.

The donor

In the case we are analyzing, the sperm affected by this mutation came from an anonymous man who was paid to donate it when he was a student, starting in 2005. His sperm was used in women for about 17 years by 67 fertility clinics in 14 countries.

The donor was unaware of the mutation, was in good health, and passed the donor selection process, so the mutation was passed on to his offspring. Genetic testing performed on him did not detect the mutation.

At least 197 babies were conceived using his sperm across Europe, according to a major investigation by 14 public broadcasters in the European Broadcasting Union’s Investigative Journalism Network.

Among them, at least 23 cases of mutation were detected among the 67 children known at that time, with ten of them diagnosed with cancer.

According to the BBC, Dr. Edwige Kasper, a cancer geneticist at the University Hospital of Rouen (France), said that “We have many children that have already developed a cancer. “We have some children that have developed already two different cancers and some of them have already died at a very early age.”

Sperm donation

There is no international standard regulating the number of times donor sperm can be used. However, each country sets its own limits. Unfortunately, according to the European Sperm Bank, these limits are often violated in some countries.

For example, in Belgium, where a single donor’s sperm can only be used by six families, 38 different women had 53 children with that donor.

In the UK, the limit is 10 families per donor.

Por ejemplo, en Bélgica, donde el esperma de un único donante solo puede ser utilizado por seis familias, 38 mujeres diferentes tuvieron 53 hijos con ese donante.

En Reino Unido el límite es de 10 familias por donante.

Prof Allan Pacey used to run a sperm bank in Sheffield and is now the deputy vice president of the Faculty of Biology Medicine and Health at the University of Manchester. He told the BBC: “We have to import from big international sperm banks who are also selling it to other countries, because that’s how they make their money, and that is where the problem begins, because there’s no international law about how often you can use the sperm.”

In the Netherlands, a single sperm donor is credited with fathering more than 550 children in at least 13 clinics in the Netherlands and other countries. One of the mothers of these children and the Donorkind Foundation (Netherlands) have filed a lawsuit against him.

In Spain, there is currently a national registry of gamete and embryo donors, and the law on assisted human reproduction techniques does not authorize more than six babies born from the same donor.

The European Society of Human Reproduction and Embryology has recently suggested imposing a limit of 50 families per donor.

Bioethical assessment

The increasing use of assisted reproduction techniques, along with the decline in fertility rates for men and women, has promoted the expansion of the use of donor gametes to achieve pregnancy.

This donation is remunerated and represents an important source of income for the clinics that use it in their assisted reproduction processes.

One of the conditions imposed to increase the number of donors is to guarantee their anonymity, so that biological paternity cannot be claimed from the children conceived with their gametes.

This anonymity makes it difficult for them to know the identity of their biological parents in the future, as well as to learn about genetically transmissible diseases they may suffer during their lifetime.

Recently, many court rulings are forcing clinics to reveal the identity of donors in response to demands from children who request it.

Although a selection process is applied to gamete donor candidates, with only a minority being accepted, the genetic diagnostic tests used to rule out transmissible mutations are very limited.

Given the increasing number of pregnancies using donor gametes, it is foreseeable that the problem we are discussing today is occurring in many other cases. And it will continue to do so in the future, generating a public health problem of unpredictable dimensions.

Furthermore, the fact that many babies are conceived with the same sperm increases the risk that some of them, in adulthood, may have children together without knowing that they are half-siblings, which increases the risk of genetic defects.

Gamete donation is yet another negative aspect of assisted reproductive technologies, which have fostered the belief in a supposed “right to a child,” for which any means might be acceptable. This is in addition to the overproduction of discarded embryos, cryopreserved embryos destined to die, their selection through preimplantation genetic diagnosis, pregnancies in postmenopausal women, surrogacy, and savior siblings.

The thriving assisted reproduction industry carries profound bioethical difficulties, related to respect for human life, the promotion of reproductive health, and the spread of methods that manipulate the biological balance that human nature establishes for the transmission of life.

In 2018, on the fortieth anniversary of the birth of Louise Brown, the first baby conceived through in-vitro fertilization, the journal Nature already warned about the controversies surrounding this technique. Today, we see that, far from being resolved, new related dilemmas urgently require a rethinking of its use.

Julio Tudela

Bioethics Observatory – Institute of Life Sciences

Catholic University of Valencia

Share This Story, Choose Your Platform!